Skip to main content
Shree Venkat, MD, Radiology, Miami, FL, University of Miami Hospital

ShreeRamananVenkatMD

Radiology Miami, FL

Interventional Neuroradiology, Vascular & Interventional Radiology

Assistant Professor of Interventional Radiology | The University of Miami Hospital and Clinics

Dr. Venkat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Venkat's full profile

Already have an account?

Summary

  • Shree Venkat, MD is an Assistant Professor of Interventional Radiology at University of Miami-Miller School of Medicine. She was born in Brooklyn, New York and grew up in Detroit, Michigan. After obtaining a BSE in Chemical engineering, and a BA in English Language and Literature at University of Michigan, she completed medical school at Wayne State University School of Medicine in Detroit. After residency, she completed her Interventional radiology (VIR) fellowship at University of Miami-Miller School of Medicine where she continues to practice.

    Dr. Venkat is Board-Certified in Diagnostic radiology with a Certificate of Added Qualification (CAQ) in Vascular and Interventional Radiology from the American Board of Radiology. Her research interests favor interventional oncology techniques to manage localized cancer with focus on chemoembolization, and tumor ablation. In this field of study, she has coauthored several publications in peer-reviewed journals as well as given invited talks in scientific meetings for example at Synergy and AIM symposium in 2016. Clinical service is also balanced with participation on the Clinical Competency committee for the VIR fellowship program.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Vascular and Interventional Radiology, 2012 - 2013
  • University of Toledo
    University of ToledoResidency, Radiology-Diagnostic, 2008 - 2012
  • Henry Ford Hospital
    Henry Ford HospitalInternship, Transitional Year, 2007 - 2008
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2007

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2025
  • OH State Medical License
    OH State Medical License 2008 - 2012
  • MI State Medical License
    MI State Medical License 2007 - 2008
  • American Board of Radiology Interventional Radiology and Diagnostic Radiology

Awards, Honors, & Recognition

  • Best Poster Award in Splenic Artery Embolization for Thrombocytopenia in Chemo Therapy Society of Interventional Radiology, 2013
  • Resident Award Jason Sheehan, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management  
    Ankit Mehta , Shree R. Venkat , Lorraine Portelance , Lynn G. Feun, Publication, 2/27/2018
  • Pancreatic Irreversible Electroporation: An Alternative to Pancreatic Metastasectomy  
    Shree Venkat and Govindarajan Naryanan, Publication, 4/1/2015
  • Treatment Options for Thrombocytopenia in Cancer Patients  
    Shivank Bhatia, MD, Shree Venkat, MD, Caio Max Rocha-Lima, MD, Eduardo Gonzalez, MD, Emily Jun, MD, Govindarajan Narayanan, MD, Publication, 12/19/2013

Other

  • A Pictorial Essay. VASCULAR DISEASE MANAGEMENT 2013:10(9):E170-E178 
    Michael O'Neill, MD , Jamie Rosenkrantz, MD , Jason Salsamendi, MD , Shree Venkat, MD , Shivank Bhatia, MD, Govindarajan Narayanan, MD
    2013

Authored Content

  • Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management.February 2018
  • Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and managementFebruary 2018

Committees

  • Assistant Director of DR Program, University Committee and Administrative Responsibilities 2018 - Present
  • Interim Clinical Service Leader, IR, Interventional Oncology, University Committee and Administrative Responsibilities 2018 - 2020
  • Director of Interventional Radiology Quality Assurance and Information Technology, University of Committee and Administrative Responsibilities 2017 - 2019

Research History

  • Sub-Investigator, lnterventional Radiologist performing RadioembollzationREAD90Y Registry
  • Sub-Investigator, Biopsies and lntratumoral injectionsVSV-IFNj3-NIS_ VYRIAD
  • Biopsies and lntratumoral injectionsThe Toca 6 Study: A Phase 1 b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects with Solid Tumors
  • Sub-Investigator, lnterventional Radiologist performing RadioembolizationTheraSphere® for Unresectable Liver Neoplasia
  • Sub-Investigator, lnterventional Radiologist performing RadioembolizationSirtex Resin Study
  • Principal InvestigatorRetrospective review of Y90 cases
  • Sub-Investigator, lnterventional Radiologist performing PancreaticA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
  • Sub-Investigator, lnterventional Radiologist performing Acoustic Pulse ThrombolysisKNOCOUT PE
  • Sub-Investigator, lnterventional Radiologist placing IVC filtersPRESERVE
  • Sub-Investigator, Biopsies and lntratumoral injectionsE7766-G000-101 : A Phase 1/1b Study of lntratumorally Administered STING Agonist E7766 in Subjects With Advanced Solid Tumors or Lymphomas
  • Sub-Investigator, Biopsies and lntratumoral injectionsJX594-REN026: A Study of Recombinant Vaccinia Virus in Combination With REGN2810 for Renal Cell Carcinoma
  • Sub-Investigator, Biopsies and lntratumoral injectionsIM-202: A Randomized, Open-Label, Multicenter, Phase 1 b/2 Trial Evaluating The Safety and Efficacy of lntratumorally-Administered llixadencel In Combination With Checkpoint lnbitor (CPI)
  • Sub-InvestigatorUnified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma and Cholangiocarcinoma
  • Sub Investigator, Biopsies and Intratumoral InjectionsRPL-001-16: An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors

Professional Memberships

  • Society of Interventional Radiology
    Member

Hospital Affiliations